3 Appointments
Help Test a New Potential Treatment for Gout
Gout is becoming a growing concern in Australia, affecting nearly one in 50 individuals in the general population. This condition is characterised by the accumulation of urate crystals in the joints, leading to sudden and intense inflammation and pain that can last from hours to several days.
Current treatments often include systemic non-steroidal anti-inflammatory drugs (NSAIDs), which may not be suitable for all patients due to potential side effects or existing health issues. The new investigational treatment aims to provide an alternative local option, targeting pain directly at the site of discomfort while minimising systemic effects.